Literature DB >> 7876977

Toxoplasma gondii in Iowa sows: comparison of antibody titers to isolation of T. gondii by bioassays in mice and cats.

J P Dubey1, P Thulliez, E C Powell.   

Abstract

Hearts of 1,000 pigs killed at an abattoir in Iowa were bioassayed for the prevalence of tissue cysts of Toxoplasma gondii. One hundred grams of cardiac muscle from each pig was homogenized, digested in pepsin solution, and bioassayed in 10 mice. Five hundred grams of heart tissue from each of a subset of 183 pigs was also bioassayed in cats. Serum collected from the heart from each pig was assayed for anti-T. gondii antibodies in the modified agglutination test using formalin-fixed whole tachyzoites. Anti-T. gondii antibodies were found in 22.2% of pigs. Viable T. gondii was isolated from a total of 170 pigs; from 50 hearts by bioassay in mice, from 58 hearts by bioassay in both mice and cats, and from 62 pigs by bioassay in cats only. The success of isolation in cats (65.6%) was approximately twice that in mice (31.7%). Percentage of isolations of T. gondii with respect to reciprocal antibody titers (in parentheses) in pigs was: 3.7% (< 20), 37.1% (20), 38.1% (40), 60% (80), 75% (200), 77% (400), 83% (800), and 75.8% (> or = 2,000 to 16,000).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876977

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  31 in total

1.  Sources of Toxoplasma gondii infection in pregnancy. Until rates of congenital toxoplasmosis fall, control measures are essential.

Authors:  J P Dubey
Journal:  BMJ       Date:  2000-07-15

2.  Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortality.

Authors:  J P Dubey; L R Ferreira; J Martins; Rima McLeod
Journal:  Parasitology       Date:  2011-11-14       Impact factor: 3.234

3.  Seroprevalence of Toxoplasma gondii in wild kangaroos using an ELISA.

Authors:  N Parameswaran; R M O'Handley; M E Grigg; S G Fenwick; R C A Thompson
Journal:  Parasitol Int       Date:  2009-02-04       Impact factor: 2.230

4.  Just one cross appears capable of dramatically altering the population biology of a eukaryotic pathogen like Toxoplasma gondii.

Authors:  Jon P Boyle; Badri Rajasekar; Jeroen P J Saeij; James W Ajioka; Matthew Berriman; Ian Paulsen; David S Roos; L David Sibley; Michael W White; John C Boothroyd
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

5.  Detection of Toxoplasma gondii in naturally infected domestic pigs in Northern Serbia.

Authors:  Ljiljana Kuruca; Ivana Klun; Aleksandra Uzelac; Aleksandra Nikolić; Branko Bobić; Stanislav Simin; Vesna Lalošević; Dušan Lalošević; Olgica Djurković-Djaković
Journal:  Parasitol Res       Date:  2017-09-27       Impact factor: 2.289

Review 6.  Toxoplasma gondii: from animals to humans.

Authors:  A M Tenter; A R Heckeroth; L M Weiss
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

7.  Seroprevalence of anti-Toxoplasma gondii antibodies in cattle and pigs in Ibadan, Nigeria.

Authors:  ThankGod Emmanuel Onyiche; Isaiah Oluwafemi Ademola
Journal:  J Parasit Dis       Date:  2013-09-03

8.  Identification of a sporozoite-specific antigen from Toxoplasma gondii.

Authors:  Dolores Hill; Cathleen Coss; J P Dubey; Kristen Wroblewski; Mari Sautter; Tiffany Hosten; Claudia Muñoz-Zanzi; Ernest Mui; Shawn Withers; Kenneth Boyer; Gretchen Hermes; Jessica Coyne; Frank Jagdis; Andrew Burnett; Patrick McLeod; Holmes Morton; Donna Robinson; Rima McLeod
Journal:  J Parasitol       Date:  2011-03-03       Impact factor: 1.276

9.  Acute virulence in mice is associated with markers on chromosome VIII in Toxoplasma gondii.

Authors:  D K Howe; B C Summers; L D Sibley
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

10.  Targeted disruption of the GRA2 locus in Toxoplasma gondii decreases acute virulence in mice.

Authors:  C Mercier; D K Howe; D Mordue; M Lingnau; L D Sibley
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.